𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines

✍ Scribed by Goro Oshima; Johan Wennerberg; Takashi Yamatodani; Elisabeth Kjellén; Hiroyuki Mineta; Anders Johnsson; Lars Ekblad

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
328 KB
Volume
138
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiolabeled cetuximab: Dose optimizatio
Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
✍ Bianca A.W. Hoeben; Janneke D.M. Molkenboer-Kuenen; Wim J.G. Oyen; Wenny J.M. Pe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 563 KB

## Abstract Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head‐and‐neck squamous cell carcinoma could be of value to select patients for EGFR‐targeted therapy. We assessed dose optimization of ^111^Indium‐DTPA‐cetuximab (^111^In‐cetuximab) for EGFR imaging in a head‐and‐neck

Epidermal growth factor receptor targete
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR

Insulin-like growth factor-1 receptor in
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma
✍ Christine H. Chung; Paula R. Pohlmann; Mace L. Rothenberg; Brian B. Burkey; Joel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 751 KB

## Abstract ## Background Recurrent head and neck squamous cell carcinoma (HNSCC) remains a difficult cancer to treat. Here, we describe a patient with HNSCC who had complete response to methotrexate (MTX) after progressing on multiple cytotoxic agents, cetuximab, and AMG‐479 (monoclonal antibody

Gene amplification and overexpression of
Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck
✍ Drs. Koichi Rikimaru; Drs. Keiko Tadokoro; Dr. Tadashi Yamamoto; Drs. Shoji Enom 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract The degree of gene amplification for epidermal growth factor receptor (EGFR) and its expression levels were examined in 4 cases of tumor lesions and their cell lines of human squamous cell carcinoma (SCC) of the oral cavity. The amplification was detected in 1 case (ZA), but not signifi

Epidermal growth factor receptor gene am
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines
✍ Dr. Ralph R. Weichselbaum; Edward J. Dunphy; Michael A. Beckett; Allen G. Tybor; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

We studied epidermal growth factor receptor (EGFR) gene amplification and expression in 11 early passage human head and neck carcinoma cell lines. Three cell lines demonstrated EGFR gene amplification and 10 lines showed an increase in EGFR mRNA when compared with normal keratinocytes, placenta, and